New features of use of moxonidine as telomerase activator

25 August 2018 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Ekaterina Dudinskaya

National Research Center for Preventive Medicine, Moscow (Russian Federation)

5 More presentations in this session

Presentation thumbnail

Cardiovascular benefits of treatment with angiotensin receptor blockers in patients with hypertension and chronic kidney disease: a systematic review and meta-analysis

Professor M. Burnier (Lausanne, CH)

Abstract Slides

Presentation thumbnail

Renal artery branch denervation: evaluation of lesion characteristics using a thermochromic liquid crystal phantom model

Associate Professor P. Kovoor (Westmead, AU)

Abstract Slides

Presentation thumbnail

Regulation of cardiac ADAM-10 activity by sympathoadrenergic modulation and the role for RAGE-sRAGE balance and myocardial remodeling

Mrs O. Zamyatkin (Saarbruecken, DE)

Presentation thumbnail

Calcium channel blocker monotherapy versus combination with renin-angiotensin system blockers in the development of new-onset diabetes mellitus in hypertensive Korean patients

Professor A. Her (Chuncheon, KR)

Presentation thumbnail

Difference in renal parenchymal perfusion after renal denervation comparing treated vs. non-treated arteries

Mr R. Schmieder (Munich, DE)

Access the full session

Session thumbnail

Hypertension treatment

The Event

ESC Congress 2018

25 August - 29 August 2018

You may be interested in

Congress Presentation

The floor is yours: bring your questions about optimal blood pressure control for organ protection - expert panel

Congress Presentation

Hypertension, diabetes, and the kidney: a triple threat for adverse cardiovascular events?

Congress Presentation

Hypertension and glucose

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources